ScholarLens Back to search
2021•Journal of Nuclear CardiologyRequires access

Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging

Jamieson M. Bourque, Christopher A. Hanson, Denis Agostini, Timothy M. Bateman, Jeroen J. Bax, Rob Beanlands, Daniel S. Berman, Ernest Garcia, Gary V. Heller, Juhani Knuuti, Nagara Tamaki, James E. Udelson, Jamshid Maddahi

Open publisher page 19 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Coronary artery disease, Myocardial perfusion imaging, Positron emission tomography, Clinical endpoint, Nuclear medicine, Radiology, CAD

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging — Research Paper | ScholarLens